These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26868493)

  • 1. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes.
    Donath MY
    Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and immunoinflammatory pathways of beta cell destruction.
    Imai Y; Dobrian AD; Morris MA; Taylor-Fishwick DA; Nadler JL
    Diabetologia; 2016 Apr; 59(4):673-8. PubMed ID: 26868492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial network regulation and its potential interference with inflammatory signals in pancreatic beta cells.
    Baltrusch S
    Diabetologia; 2016 Apr; 59(4):683-7. PubMed ID: 26873508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of leptin in diabetes: metabolic effects.
    Meek TH; Morton GJ
    Diabetologia; 2016 May; 59(5):928-32. PubMed ID: 26969486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon: acute actions on hepatic metabolism.
    Miller RA; Birnbaum MJ
    Diabetologia; 2016 Jul; 59(7):1376-1381. PubMed ID: 27115415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?
    Sathyapalan T; Atkin SL
    Minerva Endocrinol; 2011 Jun; 36(2):147-56. PubMed ID: 21519323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis.
    Perry RJ; Petersen KF; Shulman GI
    Diabetologia; 2016 May; 59(5):933-7. PubMed ID: 26961503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon action in the brain.
    Abraham MA; Lam TKT
    Diabetologia; 2016 Jul; 59(7):1367-1371. PubMed ID: 27115416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptors as new therapeutic targets for type 2 diabetes.
    Reimann F; Gribble FM
    Diabetologia; 2016 Feb; 59(2):229-33. PubMed ID: 26661410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renaissance of leptin for obesity therapy.
    Quarta C; Sánchez-Garrido MA; Tschöp MH; Clemmensen C
    Diabetologia; 2016 May; 59(5):920-7. PubMed ID: 26983921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources of beta cells inside the pancreas.
    De Groef S; Staels W; Van Gassen N; Lemper M; Yuchi Y; Sojoodi M; Bussche L; Heremans Y; Leuckx G; De Leu N; Van de Casteele M; Baeyens L; Heimberg H
    Diabetologia; 2016 Sep; 59(9):1834-7. PubMed ID: 27053238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications.
    Pollack RM; Donath MY; LeRoith D; Leibowitz G
    Diabetes Care; 2016 Aug; 39 Suppl 2():S244-52. PubMed ID: 27440839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting inflammation in the treatment of type 2 diabetes: time to start.
    Donath MY
    Nat Rev Drug Discov; 2014 Jun; 13(6):465-76. PubMed ID: 24854413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of gastrointestinal autonomic neuropathy.
    Törnblom H
    Diabetologia; 2016 Mar; 59(3):409-13. PubMed ID: 26634570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting insulin-producing beta cells for regenerative therapy.
    Migliorini A; Roscioni SS; Lickert H
    Diabetologia; 2016 Sep; 59(9):1838-42. PubMed ID: 27412250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional anti-inflammatories in the treatment and prevention of type 2 diabetes mellitus and the metabolic syndrome.
    Merone L; McDermott R
    Diabetes Res Clin Pract; 2017 May; 127():238-253. PubMed ID: 28402903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammation can cause type 2 diabetes].
    Sjöholm A; Nyström T
    Lakartidningen; 2004 May; 101(19):1716-21. PubMed ID: 15188586
    [No Abstract]   [Full Text] [Related]  

  • 19. Innate immune activation in obesity.
    Lumeng CN
    Mol Aspects Med; 2013 Feb; 34(1):12-29. PubMed ID: 23068074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and insulin resistance.
    Shoelson SE; Lee J; Goldfine AB
    J Clin Invest; 2006 Jul; 116(7):1793-801. PubMed ID: 16823477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.